The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye

Table 1 Anti-VEGF drugs and their approved indications

Drug	Approved indications
Ranibizumab [6]	nAMD, DR, DME, RVO, myopic CNV
Aflibercept [7]	nAMD, DR with DME, DME, RVO
Brolucizumab [8]	nAMD
Bevacizumab [9]	None (but often used for all of the above)

ISSN: 2056-9920